Wisconsin Ginseng for Decreasing Cancer Related Fatigue

ClinicalTrials.gov ID: NCT06395441

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06395441. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Study of Ginseng for Cancer Related Fatigue

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This symptom complex meaningfully contributes to psychosocial distress, healthcare costs, and it also interferes with the delivery of anticancer therapies. American ginseng (Western ginseng) appears to be a promising appearing agent for treating cancer related fatigue. Western ginseng may reduce cancer-related fatigue.

Study identification

NCT ID: NCT06395441
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Mayo Clinic; Other
Enrollment: 222 participants

Conditions and interventions

Conditions

Interventions

Dietary Supplement · Drug · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 1, 2024 (Actual)
Primary completion: Dec 30, 2027 (Estimated)
Completion: Dec 30, 2027 (Estimated)
Last update posted: Oct 20, 2026

2024 – 2027

United States locations

U.S. sites: 15
U.S. states: 1
U.S. cities: 15

Facility	City	State	ZIP	Site status
Mayo Clinic Health System in Albert Lea	Albert Lea	Minnesota	56007	Recruiting
Sanford Joe Lueken Cancer Center	Bemidji	Minnesota	56601	Recruiting
Essentia Health Saint Joseph's Medical Center	Brainerd	Minnesota	56401	Recruiting
Essentia Health Deer River Clinic	Deer River	Minnesota	56636	Recruiting
Essentia Health St. Mary's Detroit Lakes Clinic	Detroit Lakes	Minnesota	56501	Recruiting
Essentia Health Cancer Center	Duluth	Minnesota	55805	Recruiting
Essentia Health Fosston	Fosston	Minnesota	56542	Recruiting
Essentia Health Hibbing Clinic	Hibbing	Minnesota	55746	Recruiting
Mayo Clinic Health System-Mankato	Mankato	Minnesota	56001	Recruiting
MMCORC CentraCare Monticello Cancer Center	Monticello	Minnesota	55362	Completed
Mayo Clinic in Rochester	Rochester	Minnesota	55905	Recruiting
Essentia Health Sandstone	Sandstone	Minnesota	55072	Recruiting
Sanford Thief River Falls Medical Center	Thief River Falls	Minnesota	56701	Recruiting
Essentia Health Virginia Clinic	Virginia	Minnesota	55792	Recruiting
Sanford Worthington Medical Center	Worthington	Minnesota	56187	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06395441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 20, 2026 · Synced Nov 15, 2026